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Purpose: To describe the clinical and genetic findings in one Chinese family with late-onset bilateral lens dislocation and
secondary glaucoma.
Methods: One family including three affected members and 16 unaffected family members was examined clinically.
After informed consent was obtained, genomic DNA was extracted from venous blood of all participants. Linkage analysis
was performed with two microsatellite markers around the fibrillin-1 (FBN1) gene (D15S992 and D15S126). Mutation
screening was performed using direct DNA sequence analysis and single strand conformation polymorphism (SSCP).
Results: Clinical examination and pedigree analysis revealed that four members in three generations were affected by
late-onset lens dislocation and secondary glaucoma but had no signs of cardiovascular abnormality or abnormal skeletal
features. By genotyping, the family showed the linkage to FBN1 on 15q21.1. After mutation screening analysis on 65
exons of FBN1, a novel heterozygous missense mutation, c.2860C>T (R954C), was detected. This mutation cosegregated
with the disease phenotype in the family and was not found in 100 normal controls.
Conclusions: Late-onset isolated ectopia lentis with secondary glaucoma is consistent with a novel mutation in FBN1.
Our finding expands the spectrum of FBN1 mutations and is useful for further genetic consultation and genetic diagnosis.
Ectopia  lentis  (EL;  OMIM  129600)  is  a  dominantly
inherited  connective  disorder  characterized  by  lens
dislocation due to stretched or disrupted zonular filaments
[1]. It may also occur as a common clinical feature of several
different  systemic  hereditary  diseases  such  as  Marfan
syndrome. Marfan syndrome (MFS, OMIM 154700) is an
autosomal  dominant  connective  tissue  disorder  involving
many  systems,  but  its  more  cardinal  manifestations  are
cardiovascular, skeletal, and ocular [1]. However, isolated EL
or  simple  EL  patients  present  with  no  cardiovascular  or
skeletal features of MFS [1]. By genetic analysis, both EL and
MFS are linked to the same gene, fibrillin-1 (FBN1) [2-4].
FBN1 mutations have been identified in patients affected by
type I fibrillinopathies, which include MFS, neonatal MFS
(nMFS), MASS syndrome (mitral valve, aorta, skeleton, and
skin;  OMIM  604308),  isolated  EL,  Shprintzen-Goldberg
syndrome (OMIM 182212), isolated skeletal features of MFS,
and ascending aortic aneurysm [2-10].
FBN1 contains 65 exons spanning 230 kb of genomic
DNA  on  chromosome  15q21.1.  The  gene  encodes
profibrillin-1, a 350 kDa glycoprotein. This glycoprotein is
further processed to fibrillin-1, the main component of 10–12
nm extracellular microfibrils that are widely distributed in
both elastic and non-elastic tissues including the skin, aorta,
periosteum, cartilage, and ciliary zonules [5-8]. Fibrillin-1
contains 47 motifs with homology to the human epidermal
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growth factor (EGF); 43 of these also contain a consensus
sequence for calcium binding (cbEGF). EGF motifs have six
conserved cysteine residues that form three disulfide bonds—
between C1 and C3, C2 and C4, C5 and C6. It also has seven
TGFβ1-binding  protein-like  modules  containing  eight-
cysteine motifs (8-Cys/TB), a two-hybrid domain, a NH2-
terminal  domain,  one  proline  rich  region,  and  a  COOH-
terminal domain [6].
Here, we reported a Chinese family associated with late-
onset isolated EL and secondary glaucoma. Molecular genetic
analysis of the family revealed a novel heterozygous missense
mutation in FBN1.
METHODS
Patients  and  DNA  samples  collection:  This  study  was
approved by the Beijing Tongren Hospital Joint Committee
on  Clinical  Investigation.  After  informed  consents  were
obtained,  all  participants  underwent  physical,
ophthalmologic,  and  cardiovascular  examinations.
Ophthalmologic  examinations  included  bilateral  visual
acuity,  slit-lamp  biomicroscopy,  fundus  examination  with
dilated  pupils,  and  ultrasound  biomicroscopy  (UBM).
Cardiovascular examinations included electrocardiogram and
echocardiogram.  Peripheral  blood  was  obtained  by
venipuncture, and genomic DNA was extracted according to
standard protocols.
Linkage  analysis:  Genotyping  and  linkage  analysis  were
performed  with  two  microsatellite  markers,  D15S992  and
D15S126, around FBN1. Their detailed genetic and physical
distances are shown in Figure 1. The primer sequences of
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Human Genome Database. Genotyping and linkage analysis
were performed as described elsewhere [11,12]. LOD scores
were calculated for the two markers by two-point linkage
analysis using linkage package 5.2. We modeled the disease
as  an  autosomal  dominant  trait  with  reduced  penetrance.
Pedigree and haplotype were constructed using Cyrillic V. 2.0
software.
Mutation screening of FBN1: The whole coding region of
FBN1 was amplified by polymerase chain reaction (PCR)
from genomic DNA. Sixty-five pairs of primers for FBN1
were used according to the articles previously published [13,
14]. Nucleotide sequences were compared with the published
cDNA  sequence  of  FBN1  (GenBank  accession  number
NM_000138) using DNAssit version 1.0.
Single  strand  conformation  polymorphism:  Single  strand
conformation polymorphism (SSCP) was used to exclude the
point mutations from the normal controls. PCR amplified
DNA  fragments  were  mixed  with  an  equal  volume  of
formamide  buffer  and  electrophoresed  on  a  12%
nondenaturing  polyacrylamide  gel  (12  ml  30%  PAGE
[acrylamide:bisacrylamide=29:1];  3  ml  10X  TBE;  15  ml
distilled  water;  600  μl  10%  ammonium  persulfate,  5  μl
tetramethylethylenediamine).  After  electrophoresis,  gels
were silver-stained and analyzed.
RESULTS
Clinical findings: We have identified a Chinese family with
bilateral  lens  dislocation.  The  mode  of  inheritance  was
autosomal  dominant  (Figure  1).  The  family  had  20
individuals; four of them were affected (one male and three
females). As the mother of the proband passed away several
years ago, we did not get her blood sample. However, from
her hospital records, we inferred that she suffered the same
Figure 1. Family structure and haplotype analysis of the Chinese
family with ectopia lentis. Pedigree and haplotype analysis of the
Chinese  families  with  EL  showed  segregation  with  two
microsatellite markers on chromosome 15, listed in descending order
from the centromeric end. Squares indicate males; circles indicate
females; slashed symbols indicate that the member is deceased; solid
symbols denote that the member is affected; open symbols mean the
member is unaffected; open symbols with a dot in the center denote
that the member is an asymptomatic carrier; arrow symbol denotes
the proband.
eye  disease.  After  clinical  examinations  and  reviewing
hospital records, we found all affected members shared almost
the same clinical manifestations. All of them first experienced
the  sudden  blurring  of  vision  with  periocular  pain  and
congestion, then ophthalmologic examinations showed high
intraocular  pressure  (IOP;  40–80  mmHg),  corneal  edema,
shallow anterior chamber, and lens dislocation. All affected
members underwent lens extraction, and their IOP were in the
normal range after surgery. Fundus examination for three of
the affected individuals showed healthy and pink optic discs
with a cup/disc ratio around 0.4 (except the proband’s right
eye). Physical and cardiovascular examinations presented no
skeletal and cardiovascular features of MFS in any of the
affected  members.  Their  detailed  clinical  information  is
summarized in Table 1.
Genotyping  results:  This  family  with  isolated  EL  was
genotyped with two microsatellite markers located around
FBN1 in the 15q21.1 region. The marker results for D15S992
and D15S126 were fully informative for linkage. Haplotypes
were constructed for this family to determine whether the
disease was segregating with microsatellite markers. For this
family, there were no affected recombinants for either of the
two markers (Figure 1). Interestingly, three clinical unaffected
individuals  (III:1,  III:6,  and  III:7)  inherited  the  affected
haplotype as well. As the lens luxation in this family seemed
to represent a late-onset feature in the phenotype and all three
of them were under 37 years old (the youngest age of onset in
this family), they were obligate carriers. Their detailed clinical
information was also summarized in Table 1. Therefore, the
disease  penetrance  appeared  incomplete  in  this  pedigree.
Two-point LOD scores for D15S992 and D15S126 with 60%
penetrance were 0.70 (θ=0.0) and 2.36 (θ=0.0), respectively.
Mutation  analysis:  By  direct  sequencing  the  65  exons  of
FBN1, we identified a novel base change, C>T, at position
2860 of cDNA, replacing arginine acid with cysteine at codon
954 (Figure 2A). Using SSCP analysis, this heterozygous
mutation cosegregated with all affected members and affected
haplotype carriers in this Chinese family (Figure 2B) but was
not detected in 100 unrelated normal controls.
DISCUSSION
In this study, we analyzed a Chinese family with four members
affected by lens dislocation along with secondary glaucoma.
By genotyping, the family showed the linkage to the EL locus
on 15q21.1. One novel heterozygous FBN1 mutation, R954C,
was identified in this family. The mutation, R954C, was found
to  cosegregate  with  the  EL  phenotype,  and  where  three
clinically unaffected members carried the mutation, they were
also found to harbor the affected haplotype. This variant was
not detected in 100 normal control individuals. All affected
individuals showed ocular involvement only and did not meet
the Ghent criteria for Marfan syndrome [6]. Diagnosis of
isolated ectopia lentis was established for this family. In our
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1230Figure 2. DNA sequence chromatograms and cosegregation analysis
of the R954C mutation with disease phenotype. A: Heterozygote
sequence (sense strand) shows a C?T transition in codon 954 that
changed  arginine  (CGC)  to  cysteine  (TGC).  B:  Single  strand
conformation polymorphism (SSCP) analysis shows that the mutant
pattern (three bands) cosegregated with affected individuals and
carriers harboring heterozygous for the C?T transition but not with
unaffected individuals and spouses (two bands).
review  of  the  literature,  isolated  EL  occurs  either  as  a
congenital disorder or as a spontaneous disorder of late onset,
which is between the ages of 20 and 65 years [1,7,15]. This
family’s late-onset feature (37–51 years old) is in accordance
with the secondary condition. As three obligate carriers in this
family were still younger than 37 years old (the youngest age
of onset in this pedigree), they might develop EL in the future
or present reduced penetrance or non-penetrance as reported
before [7,15]. They should therefore undergo ophthalmologic
surveillance at regular intervals throughout their lives.
To date, over 600 mutations in FBN1 have been reported.
However, mutations for isolated EL only take a small part
(FBN1  Universal  Mutation  Database  [UMD]).  Mutation
R954C that was detected in this study is the first missense
mutation in exon 24 associated with isolated EL. Mutations
within the middle region (exons 24–32) of FBN1 are usually
associated with a severe form of MFS, neonatal MFS, and
define a high-risk group for cardiac manifestations [5-8,16].
Mutation R954C is located in the third 8-Cys/TB modules,
which contains eight cysteine residues that form four disulfide
bonds—between C1 and C3, C2 and C6, C4 and C7, and C5
and C8. This mutation adds a new cysteine residue, which
TABLE 1. CLINICAL DETAILS OF THREE AFFECTED MEMBERS AND THREE CARRIERS IN THE ECTOPIA LENTIS FAMILY.
II:1 II:8 II:11 III:1 III:6 III:7
Age 67 61 49 36 34 21
Onset age 37 54 42 - - -
Ocular features
Best corrected Visual Acuity (R/
L)
LP*/1.5 1.0/1.0 1.0/1.0 1.0/1.0 1.0/1.0 1.0/1.0
Ectopia lentis + + + - - -
Secondary glaucoma + + + - - -
Eye operation (R) LE ILV ILV - - -
Eye operation (L) PI ILV ILV - - -
Cornea CL (R) - - - - -
Myopia ? + + + + +
Retina detachment - - - - - -
Skeletal features
Height (cm) 168 160 165 174 165 162
Pectus carinatum - - - - - -
Pectus excavatum - - - - - -
Scoliosis (>20°) - - - - - -
Arachnodactyly - - - - - -
Joint hypermobility - - - - - -
Cardiovascular features
Mitralvalve prolapse - - - - - -
Aortic ascendens dilatation/
dissection
- - - - - -
R represents right eye; L represents left eye; + represents positive syndrome; - represents negative syndrome; ? represents
syndrome  is unknown; LP represents light perception; LE represents lensectomy; PI represents peripheral iridotomy; CL
represent corneal leukoma; ILS represent intraocular lens suspension; The asterisk indicates that the lens was completely
dislocated into the anterior chamber, which induced corneal endothelial decompensation and corneal opacity.
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influence the structure and function of fibrillin-1.
Early in 2002, [17] Comeglio et al. noted that mutations
involving non-conserved arginine to cysteine substitution are
usually associated with isolated EL. To date, nine of these
types of substitutions have been identified in FBN1 (Table 2)
[13,17-29]. Seven of them including the one detected in this
study definitively caused isolated EL, and the majority of
them are confined to the first 15 exons of FBN1 (5/7). Our
results  support  the  prior  suggestion  that  non-conserved
arginine  to  cysteine  substitution  is  highly  related  to
predominant EL regardless of which modules they are located
[17,18].
Another clinical feature of this family is glaucoma, which
is relatively common and a serious complication of ectopia
lentis [1]. According to the literature, glaucoma usually occurs
more frequently in spontaneous late subluxation of the lens
than  in  the  congenital  type  [1].  We  concluded  that  the
pathogenesis of glaucoma in this family was due to lens-
induced pupillary block.
In  summary,  we  described  a  novel  non-conserved
arginine to cysteine substitution in exon 24 of FBN1 that is
associated  with  late-onset  isolated  EL  and  secondary
glaucoma.  Our  results  further  expanded  the  mutation
spectrum of FBN1 and provided useful genetic consultation
and genetic diagnosis for this family.
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